@article{a7529a23d89b44628edf26c57a9d3012,
title = "Targeting CD47/sirpα in acute myeloid leukemia and myelodysplastic syndrome: Preclinical and clinical developments of magrolimab",
keywords = "AML, Azacitidine, CD47, MDS, Magrolimab",
author = "Fadi Haddad and Naval Daver",
note = "Funding Information: Source of Support: This work was supported in part by the MD Anderson Cancer Centre Support Grant (CCSG) CA016672, the MD Anderson Cancer Center Leukemia SPORE CA100632, the Charif Souki Cancer Research Fund, the Dick Clark Immunotherapy Fund, and generous philanthropic contributions to the MD Anderson Moon Shots Program.",
year = "2021",
month = may,
doi = "10.36401/JIPO-21-X2",
language = "English (US)",
volume = "4",
pages = "67--71",
journal = "Journal of Immunotherapy and Precision Oncology",
issn = "2666-2345",
publisher = "Innovative Healthcare Institute",
number = "2",
}